Researchers have validated a colorimetric method that measures urea and ammonium simultaneously in a single KCl extract and ...

A new comparative docking study ranks the anthelmintic niclosamide and the plant alkaloid berberine against three key Helicobacter pylori enzymes, prioritizing both repurposed candidates for ...

BASF and Yuntianhua are deepening their collaboration to develop and commercialise a new nitrification inhibitor in China, targeting nitrogen losses, fertiliser efficiency and emissions from agricultu ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the oral Bruton's tyrosine kinase (BTK) inhibitor remibrutinib (Rhapsido, Novartis Pharmaceuticals UK) for adults with ...

In “Spider-Man: Brand New Day,” Peter Parker invents new technology that could accidentally change the future of the Marvel Cinematic Universe. The tech, created after a conversation with Bruce Banner ...

Ziltivekimab failed to reduce the risk of 3-point MACE (HR, 0.99) vs placebo in adults with ASCVD, CKD, and CV inflammation. Topline data were announced from a phase 3 trial evaluating ziltivekimab in ...

The first experiment was conducted in a greenhouse using a completely randomized design with five treatments and four replications. Treatments consisted of a control (without N application), urea (Ur) ...

The global N-(n-propyl) thiophosphoric triamide (NPPT) urease inhibitor market is experiencing rapid expansion as agricultural producers seek to improve nitrogen use efficiency, reduce ...

Please provide your email address to receive an email when new articles are posted on . Iptacopan received traditional FDA approval for treating adults with immunoglobulin A nephropathy. The ...

Trials of current B cell-directed therapies and an investigational inhibitor of the alternative complement pathway demonstrate proteinuria reduction in patients with IgA nephropathy. Targeting ...

What Is Skyrizi, and Why Does It Matter? Skyrizi (risankizumab-rzaa) is a prescription biologic used to treat certain immune-mediated inflammatory conditions. It is now approved by the FDA for ...